IRIS Accounts Production v24.3.2.46 07286489 Board of Directors 1.7.23 30.6.24 30.6.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh072864892023-06-30072864892024-06-30072864892023-07-012024-06-30072864892022-06-30072864892022-07-012023-06-30072864892023-06-3007286489ns15:EnglandWales2023-07-012024-06-3007286489ns14:PoundSterling2023-07-012024-06-3007286489ns10:Director12023-07-012024-06-3007286489ns10:PrivateLimitedCompanyLtd2023-07-012024-06-3007286489ns10:Micro-entities2023-07-012024-06-3007286489ns10:AuditExempt-NoAccountantsReport2023-07-012024-06-3007286489ns10:FullAccounts2023-07-012024-06-3007286489ns10:Director22023-07-012024-06-3007286489ns10:RegisteredOffice2023-07-012024-06-3007286489ns5:CurrentFinancialInstruments2024-06-3007286489ns5:CurrentFinancialInstruments2023-06-30
REGISTERED NUMBER: 07286489 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 JUNE 2024

FOR

NORTH WEST ONCOLOGY LIMITED

NORTH WEST ONCOLOGY LIMITED (BY SHARES) (REGISTERED NUMBER: 07286489)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 JUNE 2024




Page

Company Information 1

Balance Sheet 2


NORTH WEST ONCOLOGY LIMITED (BY SHARES)

COMPANY INFORMATION
FOR THE YEAR ENDED 30 JUNE 2024







DIRECTORS: Dr J P Wylie
Mrs N A Wylie





REGISTERED OFFICE: Rookery Manor
Bollington Road
Bollington
Cheshire
SK10 5EL





REGISTERED NUMBER: 07286489 (England and Wales)

NORTH WEST ONCOLOGY LIMITED (BY SHARES) (REGISTERED NUMBER: 07286489)

BALANCE SHEET
30 JUNE 2024

2024 2023
£    £    £    £   
FIXED ASSETS 337,002 216,472

CURRENT ASSETS 767,327 685,563

CREDITORS
Amounts falling due within one year (121,059 ) (66,851 )
NET CURRENT ASSETS 646,268 618,712
TOTAL ASSETS LESS CURRENT
LIABILITIES

983,270

835,184

CAPITAL AND RESERVES 983,270 835,184

NOTE TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2023 - 2 ) .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 June 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 June 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

NORTH WEST ONCOLOGY LIMITED (BY SHARES) (REGISTERED NUMBER: 07286489)

BALANCE SHEET - continued
30 JUNE 2024


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors and authorised for issue on 21 March 2025 and were signed on its behalf by:





Dr J P Wylie - Director